ES554102A0 - Procedimiento para preparar un medicamento que contiene como ingrediente activo una proteina glicosilada - Google Patents

Procedimiento para preparar un medicamento que contiene como ingrediente activo una proteina glicosilada

Info

Publication number
ES554102A0
ES554102A0 ES554102A ES554102A ES554102A0 ES 554102 A0 ES554102 A0 ES 554102A0 ES 554102 A ES554102 A ES 554102A ES 554102 A ES554102 A ES 554102A ES 554102 A0 ES554102 A0 ES 554102A0
Authority
ES
Spain
Prior art keywords
preparing
procedure
active ingredient
product containing
medicinal product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES554102A
Other languages
English (en)
Other versions
ES8704544A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of ES8704544A1 publication Critical patent/ES8704544A1/es
Publication of ES554102A0 publication Critical patent/ES554102A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Saccharide Compounds (AREA)
ES554102A 1985-02-08 1986-04-17 Procedimiento para preparar un medicamento que contiene como ingrediente activo una proteina glicosilada Expired ES8704544A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3504334 1985-02-08
DE19853521226 DE3521226A1 (de) 1985-02-08 1985-06-13 Gene fuer biologisch aktive proteine

Publications (2)

Publication Number Publication Date
ES8704544A1 ES8704544A1 (es) 1987-04-01
ES554102A0 true ES554102A0 (es) 1987-04-01

Family

ID=25829228

Family Applications (2)

Application Number Title Priority Date Filing Date
ES551695A Expired ES8702493A1 (es) 1985-02-08 1986-02-06 Procedimiento para preparar proteinas eventualmente glicosiladas
ES554102A Expired ES8704544A1 (es) 1985-02-08 1986-04-17 Procedimiento para preparar un medicamento que contiene como ingrediente activo una proteina glicosilada

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES551695A Expired ES8702493A1 (es) 1985-02-08 1986-02-06 Procedimiento para preparar proteinas eventualmente glicosiladas

Country Status (11)

Country Link
US (1) US4849349A (es)
EP (1) EP0190652B1 (es)
KR (1) KR940003690B1 (es)
DE (2) DE3521226A1 (es)
DK (1) DK61486A (es)
ES (2) ES8702493A1 (es)
FI (1) FI84916C (es)
GR (1) GR860360B (es)
HU (1) HUT40167A (es)
IE (1) IE58869B1 (es)
PT (1) PT81978B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5422090A (en) * 1984-08-13 1995-06-06 Biotechnology Australia, Pty., Ltd. Human PAI-2
DE3709255A1 (de) * 1987-03-20 1988-09-29 Hoechst Ag Hybridserpine und dafuer kodierende dna
JPH01191687A (ja) * 1988-01-28 1989-08-01 Hoechst Japan Kk ヒトα↓２−プラスミンインヒビターまたはそれと類似の蛋白質から誘導される新規蛋白質
NL8902454A (nl) * 1989-10-03 1991-05-01 Stichting Centraal Lab Mutanten van de humane plasminogeen activator inhibitor 1 (pai-1), hun bereiding en toepassing, en recombinante polynucleotiden die voor deze mutanten coderende genetische informatie omvatten.
US5118793A (en) * 1989-10-20 1992-06-02 Washington University Modified heparin cofactor II
US5102995A (en) * 1989-10-20 1992-04-07 Washington University Dna encoding modified heparin cofactor ii
US5571783A (en) * 1993-03-09 1996-11-05 Clintec Nutrition Company Composition and method for treating patients with hepatic disease
DE19602345C2 (de) 1996-01-24 2002-12-12 Biotest Ag Verfahren zur Verbesserung des Wachstums und des kolorimetrischen Nachweises von Bakterien, Hefen, Pilzen oder Kokken

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2116183B (en) * 1982-03-03 1985-06-05 Genentech Inc Human antithrombin iii dna sequences therefore expression vehicles and cloning vectors containing such sequences and cell cultures transformed thereby a process for expressing human antithrombin iii and pharmaceutical compositions comprising it
BE895961A (fr) * 1983-02-21 1983-06-16 Wallone Region Procede de preparation d'un clone bacterien produisant de 1'alpha 1-antitrypsine humaine

Also Published As

Publication number Publication date
ES8702493A1 (es) 1986-12-16
KR940003690B1 (ko) 1994-04-27
IE860350L (en) 1986-08-08
FI84916C (fi) 1992-02-10
FI860540A0 (fi) 1986-02-06
EP0190652B1 (de) 1990-08-16
DK61486A (da) 1986-08-09
IE58869B1 (en) 1993-11-17
DE3673436D1 (de) 1990-09-20
ES8704544A1 (es) 1987-04-01
GR860360B (en) 1986-06-03
PT81978B (pt) 1988-07-01
ES551695A0 (es) 1986-12-16
FI860540L (fi) 1986-08-09
FI84916B (fi) 1991-10-31
KR860006484A (ko) 1986-09-11
PT81978A (de) 1986-03-01
DK61486D0 (da) 1986-02-07
HUT40167A (en) 1986-11-28
DE3521226A1 (de) 1986-08-14
EP0190652A1 (de) 1986-08-13
US4849349A (en) 1989-07-18

Similar Documents

Publication Publication Date Title
AR240250A1 (es) Procedimiento para la preparacion de una nueva formualcion farmaceutica oral que contiene omeprazol como ingrediente activo.
ES551467A0 (es) Procedimiento de preparar ingrediente activo para insecticidas
KR890701076A (ko) 온도-조절된 활성약제 디스펜서
MX17752A (es) Formulaciones farmaceuticas y procedimiento para prepararlas
DE3880593D1 (de) Arzneizubereitungen mit retardierter wirkstofffreisetzung.
AR226377A1 (es) Procedimiento para la obtencion de formulaciones medicamentosas a base de nifedipina
DK618186D0 (da) Konfektureindgiftssystem til aktive stoffer
ES550076A0 (es) Procedimiento para preparar una formulacion de aerosol de dipropionato de beclometasona
ES524892A0 (es) Un procedimiento para la preparacion de una tableta farmaceutica
MX8639A (es) Procedimiento para la obtencion de un preparado farmaceutico.
DE3863678D1 (de) Lithiumsalze enthaltende pharmazeutische zubereitungen.
FI900625A7 (fi) Lääkeaine, joka vaikuttavana aineena sisältää dihydroliponihappoa
ES528058A0 (es) Un procedimiento para preparar una formulacion de pulverizado para cabellos de aerosol
DK252786A (da) Laegemiddel mod mave-tarmsygdomme hos dyr
ES552733A0 (es) Procedimiento para preparar esteres fluorbencilicos insecticidamente activos
ES277103Y (es) Envase bolsa para productos medicinales.
ES554102A0 (es) Procedimiento para preparar un medicamento que contiene como ingrediente activo una proteina glicosilada
NZ196288A (en) Pharmaceutical active substance administration
FI883638A7 (fi) Menetelmä haavan paranemista edistävien lääkeainevalmisteiden valmistamiseksi.
DK298389A (da) Farmaceutisk praeparat til topisk anvendelse omfattende et amin-funktionelt medikament
ES1000119Y (es) Una tableta farmaceutica para administracion oral
AR230571A1 (es) Procedimiento para preparar una composicion farmaceutica
AR226334A1 (es) Procedimiento para fabricar preparados farmaceuticos
ES550093A0 (es) Procedimiento para preparar una droga de manzanilla
IT8520591A0 (it) Formulazione farmaceutica.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19971201